Skip to main navigation

Careers
Contact

Menu

Skip to content

Company
Investors
Pipeline
Platforms
- Immuno-Oncology Assets
  - G-MABs™
  - CAR-T
  - ADCs
  - iTAbs
  - Oncolytic Virus
- Pain Management Assets
  - ZTlido™
  - RTX
Translational Efficiencies

News Releases

fundamentals sub menu

Fundamentals

Year

Sorrento CEO to Present at Upcoming Investor Conferences

Nov 12, 2019

Sorrento to Present New Data on Advanced Immunotherapies at Multiple Upcoming Scientific Conferences

Nov 06, 2019

Los Angeles Court Rejects Patrick Soon-Shiong’s Attempt to Avoid Sorrento Litigation Allowing Arbitration Case to Move Forward

Oct 15, 2019

Sorrento Therapeutics Announces Closing of $25 Million Registered Direct Offering

Oct 09, 2019

Sorrento Therapeutics Announces $25 Million Registered Direct Offering

Oct 07, 2019

Scilex Holding Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

Sep 23, 2019

Dr. Henry Ji to Participate in Multiple Investment Conferences in September 2019 to Provide Corporate Updates

Sep 05, 2019

Sorrento Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Warrants

Jul 02, 2019

Sorrento Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock and Warrants

Jun 28, 2019

Sorrento Therapeutics Announces Proposed Public Offering of Common Stock and Warrants

Jun 28, 2019

Pagination

Current page 1
Page 2
Page 3
Page 4
Next page
Last page

Tools

Print Page
Email Alerts
RSS Feeds
Email Page

Clinical Trials
clinicaltrials@sorrentotherapeutics.com

Investors
investors@sorrentotherapeutics.com

Business Development
business@sorrentotherapeutics.com

Media Requests
mediarelations@sorrentotherapeutics.com

© 2017 Sorrento Therapeutics, Inc. All Rights Reserved.

Terms of Use
Privacy Policy
DMCA
Trademarks
Linking Policy

LinkedIn

MENU

Company
Investors
Pipeline
Platforms
- Immuno-Oncology Assets
- Pain Management Assets
  - RTX
  - ZTlido™
Translational Efficiencies
Careers
Contact